Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols

Rationale: lactose is the only FDA-approved carrier for dry powder inhaler (DPI) formulations in the US. Lactose carrier-based DPI products are contraindicated in patients with a known lactose allergy. Hence, inhaler formulations without lactose will benefit lactose allergic asthmatics. Objectives:...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:RSC Adv
Main Authors: Muralidharan, Priya, Mallory, Evan K., Malapit, Monica, Phan, Hanna, Ledford, Julie G., Hayes, Don, Mansour, Heidi M.
Formato: Artigo
Idioma:Inglês
Publicado: The Royal Society of Chemistry 2020
Assuntos:
Chemistry
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7689944/
https://ncbi.nlm.nih.gov/pubmed/33391731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/d0ra07203f
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares